ADHD in the News 2022-03-31

New Approach Allows Magnetic Brain Stimulation to Target Deep Brain Structures

Transcranial magnetic stimulation (TMS) is a highly precise and noninvasive brain stimulation tool approved by the U.S. Food and Drug Administration for the treatment of major depression and other conditions. TMS can only directly stimulate the outermost layer of the brain, but a recent study by researchers at the National Institute of Mental Health (NIMH) suggests that mapping a person’s brain architecture may make it possible to guide TMS to deep brain targets.

Vocal Stimming ADHD: What’s the Connection?

Stims include humming, tapping, or nail biting unconsciously. If your ADHD stimming soothes you, great! If it distracts or embarrasses you, there are ways to manage it.

Newest medications for ADHD

At the 43rd National Conference on Pediatric Health Care for nurse practitioners in Dallas, Texas, a look at the newest medications for children with attention-deficit/hyperactivity disorder.

All About ADHD and Executive Dysfunction

Executive dysfunction, which often occurs with ADHD, may cause issues with memory, focus, and time management.

Startups Make It Easier to Get ADHD Drugs. That Made Some Workers Anxious.

Digital companies such as Cerebral and Done seized on looser pandemic rules for prescribing ADHD drugs like Adderall. Some workers said they felt pressure to provide the medications.

Cognitive Behavioral Therapy for ADHD: Techniques and Options

If you’re looking for a different ADHD treatment, you might want to try cognitive behavioral therapy (CBT). Attention deficit hyperactivity disorder (ADHD) treatment aims to reduce the impact symptoms can have on your daily life. Medications can help reduce your symptoms, and therapy can teach strategies that help you understand and cope with your symptoms. But what type of therapy is best for ADHD? Cognitive behavioral therapy (CBT) may be an option.

Has TikTok convinced us all we’ve got ADHD? Doctors think so

If you've been on TikTok at all lately, it's likely you'll have come across a video (or two, or three) about Attention Deficit Hyperactivity Disorder, aka ADHD – a condition that affects people's behaviour, and can cause those with the condition to be restless, have trouble concentrating and act on impulse, according to the NHS. But, while it's great that platforms like TikTok are now being used to raise awareness of typically misunderstood conditions, including ADHD – of which women are often diagnosed significantly later than their male counterparts – is the content being put out actually correct?

Have ADHD? Here’s how to optimise your home

After being diagnosed with ADHD in 2021, Eleanor finally had the answers after years of feeling out of step with her condition.

Placebo Response and Its Predictors in ADHD

Inattention deficit hyperactivity disorder (ADHD), a high placebo response can minimize medication–placebo differences, compromising the development of novel medications. For a study, researchers sought to (1) assess placebo response in ADHD, (2) compare the accuracy of meta-regression and MetaForest in predicting placebo response, and (3) identify factors related to placebo response. A meta-analysis of randomized, placebo-controlled clinical trials examining pharmaceutical treatments for ADHD was carried out.

Adult ADHD and Women: What it looks like and why it is often overlooked.

KEY POINTS: ADHD is under-identified and under-treated in girls and women. Recent reviews indicate that ADHD is equally prevalent among males and females, and equally impairing. Women with ADHD may also experience anxiety or depression, which are more likely to be identified and treated. Existing treatments for ADHD can be helpful when adapted to the needs of women.

Caffeine could be a therapeutic arsenal to alleviate some of the ADHD symptoms

Attention Deficit Hyperactivity Disorder, or ADHD, is a psychiatric pathology for which diagnosis has increased exponentially over the last 20 years. In fact, current estimates suggest that this disorder affects between 2% and 5% of children in Spain, an average of one or two children per classroom, and up to 4% of the adult population. Despite these high incidence rates, controversy surrounds the treatment of this pathology and the therapeutic approach to it. This varies widely depending on each patient, the symptoms they present and their intensity. For this reason, experts are continuing to investigate different components and substances that may be capable of providing new treatment opportunities for patients diagnosed with ADHD.